Long non-coding RNA LINC00959 predicts colorectal cancer patient prognosis and inhibits tumor progression

被引:9
作者
Sun, Zhen-Qiang [1 ]
Chen, Chen [1 ]
Zhou, Quan-Bo [1 ]
Liu, Jin-Bo [1 ]
Yang, Shuai-Xi [1 ]
Li, Zhen [1 ]
Ou, Chun-Lin [2 ]
Sun, Xian-Tao [1 ]
Wang, Gui-Xian [1 ]
Song, Jun-Min [1 ]
Zhang, Zhi-Yong [1 ]
Yuan, Wei-Tang [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Anorectal Surg, Zhengzhou 450052, Henan, Peoples R China
[2] Cent South Univ, Canc Res Inst, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
long non-coding RNA; LINC00959; colorectal cancer; epithelial-mesenchymal transition; biomarker; EPITHELIAL-MESENCHYMAL-TRANSITION; CELL-PROLIFERATION; IDENTIFICATION; TUMORIGENESIS; METASTASIS; STATISTICS;
D O I
10.18632/oncotarget.21171
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long non-coding RNAs (lncRNAs) are increasingly implicated in tumorigenesis and cancer progression. This study focused on the relationship between the lncRNA LINC00959 and colorectal cancer (CRC). We found that LINC00959 expression was lower in CRC tissues than normal colorectal mucosae. High LINC00959 expression was negatively associated with TNM stage, distant metastasis, and lymphatic metastasis, and correlated with a better prognosis in 87 CRC cases. In vitro, LINC00959 knockdown enhanced colon cancer cell proliferation, invasion, and migration; upregulated N-cadherin and vimentin; and downregulated E-cadherin and Caspase-3. LINC00959 overexpression produced the opposite effects. These data suggest that LINC00959 inhibits tumor cell invasion and migration by suppressing epithelial-mesenchymal transition and promotes apoptosis through Caspase-3. LINC00959 may be a tumor suppressor and useful prognostic biomarker in CRC.
引用
收藏
页码:97052 / 97060
页数:9
相关论文
共 34 条
[1]   OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs [J].
Anaya, Jordan .
PEERJ COMPUTER SCIENCE, 2016, 2016 (06)
[2]  
[Anonymous], AJCC CANC STAGING MA
[4]   Long Noncoding RNAs: Cellular Address Codes in Development and Disease [J].
Batista, Pedro J. ;
Chang, Howard Y. .
CELL, 2013, 152 (06) :1298-1307
[5]   LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p [J].
Bian, Zehua ;
Jin, Liugen ;
Zhang, Jiwei ;
Yin, Yuan ;
Quan, Chao ;
Hu, Yaling ;
Feng, Yuyang ;
Liu, Heyong ;
Fei, Bojian ;
Mao, Yong ;
Zhou, Leyuan ;
Qi, Xiaowei ;
Huang, Shenlin ;
Hua, Dong ;
Xing, Chungen ;
Huang, Zhaohui .
SCIENTIFIC REPORTS, 2016, 6
[6]   Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma [J].
Chen, Na ;
Guo, Dan ;
Xu, Qiong ;
Yang, Minhui ;
Wang, Dan ;
Peng, Man ;
Ding, Yanqing ;
Wang, Shuang ;
Zhou, Jun .
ONCOTARGET, 2016, 7 (10) :11271-11283
[7]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[8]   A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics [J].
Hong, Yi ;
Downey, Thomas ;
Eu, Kong Weng ;
Koh, Poh Koon ;
Cheah, Peh Yean .
CLINICAL & EXPERIMENTAL METASTASIS, 2010, 27 (02) :83-90
[9]  
Imai Hiroo, 2015, Gan To Kagaku Ryoho, V42, P101
[10]   Epigenetic control of epithelial-mesenchymal-transition in human cancer [J].
Kiesslich, Tobias ;
Pichler, Martin ;
Neureiter, Daniel .
MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (01) :3-11